{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:13:53Z","timestamp":1791346433421,"version":"4.3.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11845-025-04107-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:17:24Z","timestamp":1762939044000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lower urinary tract dysfunction in the diabetes population: endocrinologists knowledge base and clinical practice patterns"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-0917","authenticated-orcid":false,"given":"J. S. A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Z.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Manecksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"4107_CR1","unstructured":"Dianna J. Magliano, Co-chair, Edward J. Boyko, Co-chair\u00a0(2021) IDF Diabetes Atlas, 10th edn.\u00a0scientific committee. In: International Diabetes Federation. Brussels, Belgium"},{"issue":"Suppl 1","key":"4107_CR2","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.2337\/dc25-S004","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"Committee ADAPP (2025) Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142025. Diabetes Care 48(Suppl 1):S59-85. https:\/\/doi.org\/10.2337\/dc25-S004","journal-title":"Diabetes Care"},{"key":"4107_CR3","unstructured":"National Institute for Health and Care Excellence (2022) Type 2 diabetes in adults: management (NICE guideline No. 28). London, NICE"},{"key":"4107_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urology.2017.03.040","volume":"105","author":"CA Tam","year":"2017","unstructured":"Tam CA, Helfand BT, Erickson BA (2017) The relationship between diabetes, diabetes severity, diabetes biomarkers, and the presence of lower urinary tract symptoms: findings from the National Health and Nutrition Examination Survey. Urology 105:141\u2013148. https:\/\/doi.org\/10.1016\/j.urology.2017.03.040","journal-title":"Urology"},{"issue":"2","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167\u2013178. https:\/\/doi.org\/10.1002\/nau.10052","journal-title":"Neurourol Urodyn"},{"key":"4107_CR6","doi-asserted-by":"publisher","first-page":"741748","DOI":"10.3389\/fendo.2021.741748","volume":"12","author":"C Xin","year":"2022","unstructured":"Xin C, Fan H, Xie J and others (2022) Impact of diabetes mellitus on lower urinary tract symptoms in benign prostatic hyperplasia patients: a meta-analysis. Front Endocrinol (Lausanne) 12:741748. https:\/\/doi.org\/10.3389\/fendo.2021.741748","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4107_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/nau.20533","volume":"27","author":"SR Hill","year":"2008","unstructured":"Hill SR, Fayyad AM, Jones GR (2008) Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn 27(5):362\u2013367. https:\/\/doi.org\/10.1002\/nau.20533","journal-title":"Neurourol Urodyn"},{"issue":"21","key":"4107_CR8","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/archinte.166.21.2381","volume":"166","author":"V Kupelian","year":"2006","unstructured":"Kupelian V, Wei JT, O\u2019Leary MP and others (2006) Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) survey. Arch Intern Med 166(21):2381\u20132387. https:\/\/doi.org\/10.1001\/archinte.166.21.2381","journal-title":"Arch Intern Med"},{"key":"4107_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25624","author":"A Van Huele","year":"2024","unstructured":"Van Huele A, Everaert K, Gibson W and others (2024) LUTS in older adults: definitions, comorbidity impact, patient priorities, and treatment strategies for managing daytime and\/or nighttime symptoms - ICI-RS 2024. Neurourol Urodyn. https:\/\/doi.org\/10.1002\/nau.25624","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"4107_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41391-018-0108-z","volume":"22","author":"J \u00c5kerla","year":"2019","unstructured":"\u00c5kerla J, Pesonen JS, P\u00f6yh\u00f6nen A and others (2019) Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men. Prostate Cancer Prostatic Dis 22(2):317\u2013323. https:\/\/doi.org\/10.1038\/s41391-018-0108-z","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3\u20134","key":"4107_CR11","first-page":"48","volume":"14","author":"JP Weiss","year":"2012","unstructured":"Weiss JP (2012) Nocturia: focus on etiology and consequences. Rev Urol 14(3\u20134):48\u201355","journal-title":"Rev Urol"},{"issue":"629","key":"4107_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/bmj.4.5629.492","volume":"4","author":"JB Bourke","year":"1968","unstructured":"Bourke JB, Griffin JP (1968) Diabetes mellitus in patients with benign prostatic hyperplasia. Br Med J 4(629):492\u2013493. https:\/\/doi.org\/10.1136\/bmj.4.5629.492","journal-title":"Br Med J"},{"key":"4107_CR13","doi-asserted-by":"publisher","unstructured":"Bali AS, Davis LG, Routh JC et al (2020) Severity of lower urinary tract symptoms associated with diabetes duration. J Urol [Internet] 203(Suppl 4):e695\u20136. Available from: https:\/\/doi.org\/10.1097\/JU.0000000000000903.04","DOI":"10.1097\/JU.0000000000000903.04"},{"issue":"8","key":"4107_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00210-022-02249-9","volume":"395","author":"BR Erdogan","year":"2022","unstructured":"Erdogan BR, Liu G, Arioglu-Inan E and others (2022) Established and emerging treatments for diabetes-associated lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol 395(8):887\u2013906. https:\/\/doi.org\/10.1007\/s00210-022-02249-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4107_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/bmj.l1204","volume":"365","author":"L Wei","year":"2019","unstructured":"Wei L, Lai EC, Kao-Yang YH and others (2019) Incidence of type 2 diabetes mellitus in men receiving steroid 5\u03b1-reductase inhibitors: population based cohort study. BMJ 365:1204. https:\/\/doi.org\/10.1136\/bmj.l1204","journal-title":"BMJ"},{"key":"4107_CR16","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1172\/JCI131126","volume":"130","author":"AE O'Mara","year":"2020","unstructured":"O\u2019Mara AE, Johnson JW, Linderman JD and others (2020) Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest 130:2209\u20132219. https:\/\/doi.org\/10.1172\/JCI131126","journal-title":"J Clin Invest"},{"key":"4107_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2490-13-12","volume":"13","author":"SK Van Den Eeden","year":"2013","unstructured":"Van Den Eeden SK, Ferrara A, Shan J and others (2013) Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol 13:12. https:\/\/doi.org\/10.1186\/1471-2490-13-12","journal-title":"BMC Urol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04107-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:14:48Z","timestamp":1772874888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04107-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04107-y","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}